Cleveland Clinic receives $2.75M grant to study stem cell use in treating MS
The Cleveland Clinic has received a $2.75 million federal grant from the Department of Defense. The study will investigate patients with relapse-remitting MS that are still able to walk but have moderate to severe disability.